Palatin Technologies Inc (PTN): Total Liabilities
$1.84M
As of 2026-06-30
$2.69M
As of 2026-09-30
-54.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.84M | -77.2% | 2026-09-28, Balance as of period end |
| 2025-06-30 | $8.04M | -25.9% | 2026-09-28, Balance as of period end |
| 2024-06-30 | $10.85M | -44.8% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $19.66M | n/c | 2024-09-30, Balance as of period end |
| 2022-06-30 | $19.80M | +12.2% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $17.65M | +261.5% | 2022-09-22, Balance as of period end |
| 2020-06-30 | $4.88M | +16.6% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $4.19M | -65.3% | 2020-09-25, Balance as of period end |
| 2018-06-30 | $12.05M | -80.6% | 2019-09-12, Balance as of period end |
| 2017-06-30 | $62.00M | +118.0% | 2018-09-13, Balance as of period end |
| 2016-06-30 | $28.44M | +64.7% | 2017-09-25, Balance as of period end |
| 2015-06-30 | $17.27M | +523.4% | 2016-09-19, Balance as of period end |
| 2014-06-30 | $2.77M | +32.2% | 2015-09-18, Balance as of period end |
| 2013-06-30 | $2.10M | -41.0% | 2014-09-12, Balance as of period end |
| 2012-06-30 | $3.55M | +19.1% | 2013-09-27, Balance as of period end |
| 2011-06-30 | $2.98M | n/a | 2012-09-10, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | $1.84M | -77.2% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $32.02M | +37.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $19.38M | -32.0% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $5.49M | -10.4% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $38.11M | +4.6% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $85.04M | +6.2% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $18.04M | -47.5% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $34.90M | +208.9% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $72.68M | +65.0% |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗